Clinical trial
A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
NCT04539236 is registered in ClinicalTrials.gov with Mikkael Sekeres, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
- Lead sponsor
- Mikkael Sekeres, MD
- Phase
- Phase 1/2
- Overall status
- Suspended
- Start date
- November 9, 2021
- Completion date
- August 1, 2029
- Enrollment
- 50 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.